GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tilray Brands Inc (FRA:2HQ) » Definitions » EBITDA Margin %
中文

Tilray Brands (FRA:2HQ) EBITDA Margin % : -35.31% (As of Feb. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Tilray Brands EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Tilray Brands's EBITDA for the three months ended in Feb. 2024 was €-61.6 Mil. Tilray Brands's Revenue for the three months ended in Feb. 2024 was €174.6 Mil. Therefore, Tilray Brands's EBITDA margin for the quarter that ended in Feb. 2024 was -35.31%.


Tilray Brands EBITDA Margin % Historical Data

The historical data trend for Tilray Brands's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tilray Brands EBITDA Margin % Chart

Tilray Brands Annual Data
Trend Aug14 May15 May16 May17 May18 May19 May20 May21 May22 May23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.39 -11.81 -47.99 -39.21 -203.06

Tilray Brands Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -804.84 -24.24 -4.51 -4.84 -35.31

Competitive Comparison of Tilray Brands's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Tilray Brands's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tilray Brands's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tilray Brands's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Tilray Brands's EBITDA Margin % falls into.



Tilray Brands EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Tilray Brands's EBITDA Margin % for the fiscal year that ended in May. 2023 is calculated as

EBITDA Margin %=EBITDA (A: May. 2023 )/Revenue (A: May. 2023 )
=-1171.546/576.954
=-203.06 %

Tilray Brands's EBITDA Margin % for the quarter that ended in Feb. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Feb. 2024 )/Revenue (Q: Feb. 2024 )
=-61.641/174.591
=-35.31 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tilray Brands  (FRA:2HQ) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Tilray Brands EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Tilray Brands's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tilray Brands (FRA:2HQ) Business Description

Traded in Other Exchanges
Address
265 Talbot Street West, Leamington, ON, CAN, N8H 5L4
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products and alcohol.

Tilray Brands (FRA:2HQ) Headlines

No Headlines